Mon, September 21, 2009
Fri, September 18, 2009
Thu, September 17, 2009
Wed, September 16, 2009
Tue, September 15, 2009
Mon, September 14, 2009
Fri, September 11, 2009
Thu, September 10, 2009
Wed, September 9, 2009
Tue, September 8, 2009
Sun, September 6, 2009
Fri, September 4, 2009
Thu, September 3, 2009
Wed, September 2, 2009
Tue, September 1, 2009
Mon, August 31, 2009
Fri, August 28, 2009
Thu, August 27, 2009
Wed, August 26, 2009
Tue, August 25, 2009
Mon, August 24, 2009
Sun, August 23, 2009
Fri, August 21, 2009
Thu, August 20, 2009
Wed, August 19, 2009
Tue, August 18, 2009
Mon, August 17, 2009
Sun, August 16, 2009
Fri, August 14, 2009
Thu, August 13, 2009
Wed, August 12, 2009
Tue, August 11, 2009
Mon, August 10, 2009
Fri, August 7, 2009
Thu, August 6, 2009
Wed, August 5, 2009
Tue, August 4, 2009
Mon, August 3, 2009
Sat, August 1, 2009
Fri, July 31, 2009
Thu, July 30, 2009
Wed, July 29, 2009

IMRIS appoints Kelly McNeill as Chief Financial Officer


//health-fitness.news-articles.net/content/2009/ .. ts-kelly-mcneill-as-chief-financial-officer.html
Published in Health and Fitness on , Last Modified on 2009-08-25 06:11:52 by Market Wire   Print publication without navigation


 WINNIPEG, Aug. 25 /CNW/ - (TSX:IM) - IMRIS Inc. (TSX: IM) ("IMRIS" or the "Company") today announced the appointment of Kelly McNeill as Executive Vice President, Finance and Administration and Chief Financial Officer. Mr. McNeill replaces Ron Sabourin who is retiring after serving as IMRIS's CFO since its founding in 2005. Mr. McNeill, a Chartered Accountant, brings a wealth of experience to IMRIS, having worked in the biotechnology and manufacturing industries as well as in both publicly traded and privately held companies. Most recently, Mr. McNeill held the position of Chief Financial Officer with Resverlogix Corp., a publicly traded biotechnology company. He is a member of the Institute of Chartered Accountants of Alberta and holds a Masters of Accountancy and Bachelor of Commerce (Honours) from the University of Manitoba. "With a strong financial background and significant experience in the biotech and manufacturing sectors, as well as expertise across all aspects of public company finance, Kelly is well suited to contribute to IMRIS's success going forward," said David Graves, President & CEO. "We are very pleased to welcome him to the IMRIS team." "I also want to take this opportunity to recognize the outstanding contribution Ron Sabourin has made to our company and the tremendous role he has played in advancing our business to where we are today," added Mr. Graves. "On behalf of the entire IMRIS team, I would like to thank Ron for his service, and wish him all the best in his retirement." Mr. McNeill will assume his position effective September 21, 2009. About IMRIS IMRIS (TSX: IM) is a global leader in providing fully integrated, advanced surgical imaging solutions. The company's flagship product, IMRISneuro, utilizes patented technology that allows a high field MRI scanner to be moved in to the operating room on demand, providing imaging during the surgical procedure without compromising patient safety. This unique and innovative system has been validated by leading neurosurgeons for use in world-class neuroscience centers. 
For further information: Brad Woods, Director Investor Relations & Corporate Communications, IMRIS Inc., Tel: (204) 480-7094, Email: [ bwoods@imris.com ]

Publication Contributing Sources